In 2025, Cohance Lifesciences conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 |
|---|---|---|
Total Waste Generated | 5,149.97a | 8,810.1a |
Total Waste Recovered | 2,193.8a | N/A |
Total Hazardous Waste Generated | 3,982.57a | 5,936.5a |
Non-Hazardous Waste Disposed | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Cohance Lifesciences generated a total of 5,150metric tonnes of waste.a
Of this amount, 42.6% of Cohance Lifesciences's total waste generated was recovered through methods such as recycling, reuse, or composting, while 56.61% was disposed of through landfilling, incineration, or combustion.a
In 2025, Cohance Lifesciences reported a total waste generation of 5,150 metric tonnes, of which 42.6% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Cohance Lifesciences is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2025, Cohance Lifesciences's total waste generation has decreased by 41.54%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.a
In 2025, Cohance Lifesciences generated a total of 5,150 metric tonnes of waste.a
Of this amount, 77.33% of Cohance Lifesciences's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.22.67% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2025, Cohance Lifesciences's total waste generation has decreased by 41.54%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.a
Overall, Cohance Lifesciences's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a